Ignite Creation Date:
2025-12-24 @ 1:47 PM
Ignite Modification Date:
2026-01-02 @ 1:00 AM
Study NCT ID:
NCT00379795
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2006-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-21
First Submit QC Date:
None
Study First Post Date:
2006-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-01
Results First Submit QC Date:
None
Results First Post Date:
2012-01-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-05
Last Update Post Date:
2017-05-11
Last Update Post Date Type:
ACTUAL